Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.80 +0.28 (+3.35%)
As of: Nov 11, 2026 · 3:59 PM EST

Aspire-Lakewood Holdings (ASBP) Long-Term Debt Repayments (2022 - 2026)

Updated

Aspire Biopharma Holdings (ASBP) recorded Long-Term Debt Repayments of $2.17 million in Q1 2026, up 881.9% from $221,390 a year earlier.

Analysis

Aspire-Lakewood Holdings (ASBP) Long-Term Debt Repayments (2022 - 2026) Analysis & Trends

For FY2025, Aspire Biopharma Holdings reported Long-Term Debt Repayments of $3.03 million.

  • Quarterly Long-Term Debt Repayments has ranged from -$221,390 in Q4 2025 to $3.03 million in Q3 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Aspire-Lakewood Holdings 63.98 Mn 43.01 Mn -30,086.00 499,214.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 499,214.00
Mar 31, 2026 3.06 Mn
Dec 31, 2025 500,000.00
Sep 30, 2025 3.01 Mn
Mar 31, 2025 221,390.00
Mar 31, 2022 252,915.00
API Access

Aspire-Lakewood Holdings Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ASBP&period=max&api_key=YOUR_API_KEY